Direct oral anticoagulants versus low-molecular-weight heparins for venous thromboembolism prevention following total hip replacement: Comparative effectiveness and medical costs from a French nationwide cohort study of around 120 000 patients

被引：0

作者：

Blin, Patrick ^{[1
]}

Samama, Charles-Marc ^{[2
]}

Sautet, Alain ^{[3
]}

Mismetti, Patrick ^{[4
]}

Benichou, Jacques ^{[5
]}

Lignot-Maleyran, Severine ^{[1
]}

Lamarque, Stephanie ^{[1
]}

Lorrain, Simon ^{[1
]}

Lassalle, Regis ^{[1
]}

Gaudin, Anne-Francoise ^{[6
]}

Cotte, Francois-Emery ^{[6
]}

Droz-Perroteau, Cecile ^{[1
]}

Moore, Nicholas ^{[7
]}

机构：

[1] Univ Bordeaux, Bordeaux PharmacoEpi, INSERM, CIC1401, Bordeaux, France

[2] Cochin Hosp, Paris, France

[3] St Antoine Hosp, Paris, France

[4] St Etienne Univ Hosp, St Etienne, France

[5] Rouen Univ Hosp, Rouen, France

[6] Bristol Myers Squibb, Rueil Malmaison, France

[7] Univ Bordeaux, Bordeaux PharmacoEpi, INSERM, CIC1401,U1219, Bordeaux, France

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：33 / 33

页数：1

共 30 条

[21] The comparative effectiveness of direct oral anti-coagulants and low molecular weight heparins for prevention of recurrent venous thromboembolism in cancer: The CANVAS pragmatic randomized trial.
Schrag, Deborah
Uno, Hajime
Rosovsky, Rachel Pam Greenerger
Rutherford, Cynthia
Sanfilippo, Kristen Marie
Villano, John L.
Drescher, Monic R.
Jayaram, Nagesh H.
Holmes, Chris E.
Feldman, Lawrence Eric
Zattra, Ottavia
Cronin, Christine
Basch, Ethan M.
Weiss, Anna
Connors, Jean M.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[22] Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism Is Associated with a Significant Decrease in Incidence of Bleeding Compared to Vitamin K Antagonists and Low-Molecular-Weight Heparins
Patel, Ameet
Williams, Hants
Baer, Maria R.
Zimrin, Ann Butler
Law, Jennie Y.
BLOOD, 2017, 130
[23] Thromboprophylaxis and total hip replacement: A cost-efficacy study comparing duplex screening of asymptomatic venous thrombosis versus prolonged prophylaxis with low-molecular-weight heparins
Barrellier, MT
PHLEBOLOGY, 2002, 17 (3-4) : 93 - 97
[24] COMPARISON OF HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH VENOUS THROMBOEMBOLISM RECEIVING DIRECT-ACTING ORAL ANTICOAGULANTS OR LOW MOLECULAR WEIGHT HEPARINS: A REAL-WORLD DATA ANALYSIS
Okoye, G.
Ben-Umeh, K.
Avancena, A.
Onukwugha, E.
VALUE IN HEALTH, 2024, 27 (06) : S63 - S63
[25] COST-EFFECTIVENESS OF ENOXAPARIN (LOW-MOLECULAR-WEIGHT HEPARIN) VERSUS WARFARIN FOR THE PREVENTION OF DEEP-VEIN THROMBOSIS FOLLOWING TOTAL HIP-REPLACEMENT
ANDERSON, DR
OBRIEN, BJ
GOREE, R
BLOOD, 1993, 82 (10) : A613 - A613
[26] Evaluation of Differences in Medical Costs Associated with Venous Thromboembolism Prophylaxis with Desirudin Vs. Low Molecular Weight Heparin Among Patients Undergoing Total Hip Replacement Surgery
Deitelzweig, Steven
Nutescu, Edith A.
Meyer, James
Lin, Jay
Lingohr-Smith, Melissa
Amin, Alpesh N.
BLOOD, 2014, 124 (21)
[27] AN EQUIVALENCE STUDY OF 2 LOW-MOLECULAR-WEIGHT HEPARINS (LMWH) IN THE PREVENTION OF DEEP-VEIN THROMBOSIS (DVT), AFTER TOTAL HIP-REPLACEMENT (THR) (440 PATIENTS)
PLANES, A
CHASTANG, C
VOCHELLE, N
DESMICHELS, D
FIESSINGER, JN
THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 651 - 651
[28] Cost-effectiveness of direct oral anticoagulants (DOAC) versus low-molecular weight heparin (LMWH) For treatment of venous thromboembolism (VTE) in gastrointestinal (GI) cancer patients
Shin, Young Eun
Wu, Wenchen
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 415 - 415
[29] Effectiveness and Safety of Direct Oral Anticoagulants Versus VKA: A Cohort Study of About 100,000 Non-Valvular Atrial Fibrillation from the Nationwide French Claims and Hospitalisation Database
Blin, Patrick
Dureau-Pournin, Caroline
Abouelfath, Abdelilah
Lassalle, Regis
Benichou, Jacques
Cottin, Yves
Mismetti, Patrick
Droz-Perroteau, Cecile
Moore, Nicholas
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 442 - 442
[30] Prescription and long-term use of low-molecular-weight heparins (LMWH) in routine medical practice for the treatment of venous thromboembolism in patients with cancer: TROPIQUE, a prospective, French national, multicenter, observational study
Farge-Bancel, D.
Cajfinger, F.
THROMBOSIS RESEARCH, 2014, 133 : S185 - S186

← 1 2 3 →